Can the Neutrophil to Lymphocyte Ratio Predict Complete Pathologic Response to Neoadjuvant Breast Cancer Treatment? A Systematic Review and Meta-analysis
Carolyn Cullinane, Ben Creavin, Donal Peter O’Leary, Martin J. O’Sullivan, Louise Kelly, H. P. Redmond, Mark Corrigan
Topics & Concepts
MedicineBreast cancerInternal medicineHazard ratioOncologyNeutrophil to lymphocyte ratioNeoadjuvant therapyConfidence intervalOdds ratioInflammatory breast cancerCancerSurrogate endpointClinical endpointMeta-analysisProspective cohort studyClinical trialLymphocyteInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersBreast Cancer Treatment Studies